QQ客服 官方微博 反馈留言

	Efficacy and Safety of Teriflunomide in Chinese Patients with Relapsing Forms of Multiple Sclerosis: A Subgroup Analysis of the Phase 3 TOWER Study
	Qiu, Wei; Huang, De-Hui; Hou, Shi-Fang; Zhang, Mei-Ni; Jin, Tao; Dong, Hui-Qing; Peng, Hua; Zhang, Chao-Dong; Zhao, Gang; Huang, Yi- 更多
刊名	CHINESE MEDICAL JOURNAL
	2018
卷号	131期号:23页码:2776-2784
关键词	Chinese Patients Efficacy Phase 3 Relapsing Multiple Sclerosis Safety Teriflunomide TOWER
DOI	10.4103/0366-6999.246067
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4571641
专题	山东大学
作者单位	1.Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou 510000, Guangdong, Peoples R China. 2.[Huang, De-Hui 3.Wu, Wei-P
推荐引用方式 GB/T 7714	Qiu, Wei,Huang, De-Hui,Hou, Shi-Fang,et al. Efficacy and Safety of Teriflunomide in Chinese Patients with Relapsing Forms of Multiple Sclerosis: A Subgroup Analysis of the Phase 3 TOWER Study[J]. CHINESE MEDICAL JOURNAL,2018,131(23):2776-2784.
APA	Qiu, Wei.,Huang, De-Hui.,Hou, Shi-Fang.,Zhang, Mei-Ni.,Jin, Tao.,...&Huang, Yi- 更多.(2018).Efficacy and Safety of Teriflunomide in Chinese Patients with Relapsing Forms of Multiple Sclerosis: A Subgroup Analysis of the Phase 3 TOWER Study.CHINESE MEDICAL JOURNAL,131(23),2776-2784.
MLA	Qiu, Wei,et al."Efficacy and Safety of Teriflunomide in Chinese Patients with Relapsing Forms of Multiple Sclerosis: A Subgroup Analysis of the Phase 3 TOWER Study".CHINESE MEDICAL JOURNAL 131.23(2018):2776-2784.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。